Medicus Pharma (MDCX) Interest Expenses (2023 - 2026)
Medicus Pharma's (MDCX) quarterly Interest Expenses came in at $115492.0 in Q4 2025, up 229.6% YoY from $35040.0 in Q4 2024, and down 55.06% on a QoQ basis from $256969.0 in Q3 2025.
Medicus Pharma (MDCX) Interest Expenses (2023 - 2026) Analysis & Trends
Medicus Pharma (MDCX) has 3 years of Interest Expenses data on file, last reported at $115492.0 in Q4 2025.
- Quarterly Interest Expenses rose 229.6% year-over-year to $115492.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $185572.0 (up 164.8% YoY) and the FY2025 annual result came in at $14.2 million, up 115.81% from the prior year.
- Interest Expenses slipped to $115492.0 in Q4 2025, from $256969.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $328101.0 in Q1 2025 to a low of $2.15 in Q4 2023.
- A 3-year average of $151957.9 and a median of $115492.0 in 2025 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses jumped 1629667.44% — and 2025, when it jumped 229.6%.
- Tracing MDCX's Interest Expenses over 3 years: stood at $2.15 in 2023, then surged by 1629667.44% to $35040.0 in 2024, then jumped by 229.6% to $115492.0 in 2025.
- The last three Interest Expenses figures came in at $115492.0 (Q4 2025), $256969.0 (Q3 2025), and $293061.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 462.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 435.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -244.19 Mn |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | 205,638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 205,638.00 |
| Jun 30, 2026 | 205,638.00 |
| Dec 31, 2025 | 115,492.00 |
| Dec 31, 2025 | 115,492.00 |
| Sep 30, 2025 | 256,969.00 |
| Sep 30, 2025 | 256,969.00 |
| Jun 30, 2025 | 293,061.00 |
| Jun 30, 2025 | 293,061.00 |
| Mar 31, 2025 | 328,101.00 |
| Mar 31, 2025 | 328,101.00 |
| Dec 31, 2024 | 35,040.00 |
| Dec 31, 2024 | 35,040.00 |
| Sep 30, 2024 | 35,040.00 |
| Sep 30, 2024 | 35,040.00 |
| Dec 31, 2023 | 2.15 |
| Dec 31, 2023 | 2.15 |